Effective Use of Tables and Figures in Clinical Manuscript Writing

Tables and figures are essential components of any scientific manuscript. They convey complex data in a simplified and digestible format, allowing readers to understand results quickly. In clinical trial documentation, visuals support narrative clarity and enhance the scientific rigor of the manuscript. This tutorial outlines how to create and format effective tables and figures for pharma professionals and clinical trial writers, ensuring compliance with global publication and regulatory standards.

Whether presenting stability data, trial outcomes, or adverse event breakdowns, visuals align your content with expectations from both journals and regulatory reviewers such as EMA.

Why Tables and Figures Matter in Manuscripts:

Well-designed tables and figures:

• Summarize complex data succinctly
• Improve reader comprehension
• Support claims made in the Results and Discussion sections
• Help reviewers and regulatory authorities evaluate findings efficiently

They are especially useful in Stability Studies and pharmacokinetic/pharmacodynamic analyses, where trends and variations need visual reinforcement.

When to Use Tables vs Figures:

Each visual format serves a different purpose:

• Tables: Use for presenting precise numerical values, comparisons, and structured datasets (e.g., demographic breakdown, AE listings, dosing schedule).
• Figures: Use to highlight trends, relationships, or differences (e.g., Kaplan-Meier curves, line graphs of stability data, bar charts of efficacy outcomes).

Balance the number of visuals. Overuse can overwhelm, while underuse can underrepresent critical findings.

Formatting Tables for Regulatory and Journal Standards:

Follow these formatting best practices for tables:

• Number sequentially (Table 1, Table 2, etc.) as per order of citation
• Include a descriptive title above each table
• Provide footnotes to explain abbreviations, symbols, or statistical significance
• Use consistent decimal places and units throughout
• Avoid merging cells or complex formatting — simplicity is key

Adopt style guides such as ICMJE, AMA, or specific journal templates. In submissions to ICH-aligned agencies, tables must also adhere to GMP documentation standards, particularly when embedded in regulatory CTD documents.

Best Practices for Figures in Clinical Manuscripts:

Figures must convey insights visually without distorting data. Consider the following:

1. Use clear legends and axis labels
2. Ensure all data points are visible and scales are appropriate
3. Color-code only if publishing guidelines allow
4. Provide figure titles and brief captions beneath the figure
5. Save high-resolution images (300 dpi or more) for submission

Types of commonly used figures include:

• Line graphs (e.g., response over time)
• Bar charts (e.g., endpoint comparison)
• Pie charts (e.g., AE distribution)
• Forest plots (e.g., subgroup analysis)
• Survival curves (e.g., Kaplan-Meier)

Use tools like GraphPad Prism, R, or Excel for creating scientific-quality visuals that conform to pharmaceutical validation standards.

Labeling and Referencing Tables and Figures:

Maintain consistency throughout the manuscript:

• Refer to each table or figure by number in the text (e.g., “see Table 3”)
• Avoid phrases like “the following table” — always specify the number
• Describe the key takeaways in the narrative, not just a restatement of the table
• Ensure placement close to first citation in the manuscript if possible

Keep titles concise and informative. For example: “Table 2. Treatment-Emergent Adverse Events by System Organ Class (≥5%)”.

Checklist for Visual Data Compliance:

Ensure all visuals meet both publication and regulatory expectations:

• Numbered sequentially and cited in order
• Descriptive captions and legends
• Consistent font size, layout, and terminology
• No duplication of data across text and visuals
• Graphics adhere to pharmaceutical compliance norms (e.g., traceability of values)

Common Pitfalls in Tables and Figures:

• Overly complex visuals that confuse rather than clarify
• Inconsistent abbreviations or data formatting
• Redundant tables and figures showing the same data
• Lack of units, unclear labels, or truncated values
• Improper scaling or omission of confidence intervals

Use a quality review checklist to ensure consistency during CSR or manuscript development phases.

Using Templates and SOPs for Table and Figure Creation:

Standard operating procedures streamline visual consistency across documents. Refer to templates from Pharma SOPs for guidance on tabular format, especially in repetitive documents like clinical study reports (CSRs) or investigator brochures.

Conclusion:

Tables and figures enhance the clarity, readability, and impact of scientific manuscripts. When used correctly, they serve as powerful tools for clinical trial professionals to present their findings accurately and persuasively. By following structured best practices — from formatting and labeling to ethical representation and regulatory compliance — pharma professionals can ensure their manuscripts are ready for both peer review and regulatory scrutiny.

Always remember, visuals are not just supportive content — they are evidence. Present them with as much care and precision as you would the manuscript’s narrative.